Trulieve Cannabis Corp. (CNSX:TRUL) Stock Price & Quote Analysis

TRUL Stock Overview

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company.

TRUL fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	4/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 37.7% below our estimate of its fair value

Earnings are forecast to grow 95.94% per year

Risk Analysis

No risks detected for TRUL from our risk checks.

My Notes

New

Notes are coming soon

Trulieve Cannabis Corp. Competitors

Cronos Group

TSX:CRON

CA$1.3b

Verano Holdings

CNSX:VRNO

CA$1.3b

Green Thumb Industries

CNSX:GTII

CA$2.4b

Cresco Labs

CNSX:CL

CA$958.3m

Price History & Performance

Summary of all time highs, changes and price drops for Trulieve Cannabis
Historical stock prices
Current Share Price	CA$8.54
52 Week High	CA$34.55
52 Week Low	CA$8.08
Beta	1.86
1 Month Change	-16.76%
3 Month Change	-46.22%
1 Year Change	-64.04%
3 Year Change	-40.45%
5 Year Change	n/a
Change since IPO	-14.43%

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Jan 26

Recent updates

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Jan 26

Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?

Aug 07

Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?

Jul 03

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well

Mar 21

Is Trulieve Cannabis Corp.'s(CSE:TRUL) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 02

Could The Trulieve Cannabis Corp. (CSE:TRUL) Ownership Structure Tell Us Something Useful?

Jan 15

Investors Who Bought Trulieve Cannabis (CSE:TRUL) Shares A Year Ago Are Now Up 186%

Dec 16

Trade Alert: The Director Of Trulieve Cannabis Corp. (CSE:TRUL), Susan Thronson, Has Just Spent US$64k Buying 65% More Shares

Nov 27

Trulieve Cannabis Corp. Just Missed Earnings - But Analysts Have Updated Their Models

Nov 19

If You Like EPS Growth Then Check Out Trulieve Cannabis (CSE:TRUL) Before It's Too Late

Nov 17

Can You Imagine How Trulieve Cannabis' (CSE:TRUL) Shareholders Feel About The 47% Share Price Increase?

Jul 13

Shareholder Returns

	TRUL	CA Pharmaceuticals	CA Market
7D	-6.2%	-3.7%	0.6%
1Y	-64.0%	-59.1%	-0.6%

Return vs Industry: TRUL underperformed the Canadian Pharmaceuticals industry which returned -59.1% over the past year.

Return vs Market: TRUL underperformed the Canadian Market which returned -0.6% over the past year.

Price Volatility

Is TRUL's price volatile compared to industry and market?
TRUL volatility
TRUL Average Weekly Movement	12.2%
Pharmaceuticals Industry Average Movement	14.2%
Market Average Movement	9.9%
10% most volatile stocks in CA Market	19.2%
10% least volatile stocks in CA Market	3.9%

Stable Share Price: TRUL is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: TRUL's weekly volatility (12%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1940	8,000	Kim Rivers	https://www.trulieve.com

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.

Trulieve Cannabis Corp. Fundamentals Summary

How do Trulieve Cannabis's earnings and revenue compare to its market cap?
TRUL fundamental statistics
Market Cap	CA$1.59b
Earnings (TTM)	-CA$263.90m
Revenue (TTM)	CA$1.65b

1.0x

P/S Ratio

-6.0x

P/E Ratio

Is TRUL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
TRUL income statement (TTM)
Revenue	US$1.24b
Cost of Revenue	US$537.00m
Gross Profit	US$705.96m
Other Expenses	US$904.19m
Earnings	-US$198.23m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-1.07
Gross Margin	56.80%
Net Profit Margin	-15.95%
Debt/Equity Ratio	27.5%

How did TRUL perform over the long term?

See historical performance and comparison

TRUL Stock Overview

Rewards

Risk Analysis

Trulieve Cannabis Corp. Competitors

TSX:CRON

CA$1.3b

CNSX:VRNO

CA$1.3b

CNSX:GTII

CA$2.4b

CNSX:CL

CA$958.3m

Price History & Performance

Recent News & Updates

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Trulieve Cannabis Corp. Launches Highsman Cannabis Products from NFL Legend Ricky Williams in Arizona

Trulieve Cannabis Corp. Announces Resignation of Rebecca L. Young as Chief Accounting Officer

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Maryland Through Exclusive Partnership with Wiz Khalifa

Trulieve Launches Khalifa Kush Cannabis in Pennsylvania Through Exclusive Partnership with Wiz Khalifa

Trulieve Cannabis Corp. Provides Earnings Guidance for the Year 2022

Recent updates

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Trulieve Cannabis Corp. Launches Highsman Cannabis Products from NFL Legend Ricky Williams in Arizona

Trulieve Cannabis Corp. Announces Resignation of Rebecca L. Young as Chief Accounting Officer

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Maryland Through Exclusive Partnership with Wiz Khalifa

Trulieve Launches Khalifa Kush Cannabis in Pennsylvania Through Exclusive Partnership with Wiz Khalifa

Trulieve Cannabis Corp. Provides Earnings Guidance for the Year 2022

Trulieve Cannabis Corp. to Report Q3, 2022 Results on Nov 09, 2022

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Florida Through Exclusive Partnership with Wiz Khalifa

Trulieve Announces Opening of Relocated Edgewater Dispensary in Florida

Second quarter 2022 earnings: EPS misses analyst expectations

Trulieve Cannabis Corp. Revises Revenue Guidance for the Fiscal Year 2022

Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?

Trulieve Cannabis Corp. to Report Q2, 2022 Results on Aug 10, 2022

Consensus forecasts updated

Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?

Founder recently bought CA$260k worth of stock

Trulieve Cannabis Corp. Opens Two Medical Dispensary in West Virginia

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Trulieve Cannabis Corp. Reiterates Earnings Guidance for 2022 and Provides Earnings Guidance for the Second Half of 2022

High number of new directors

Consensus forecasts updated

Consensus forecasts updated

Consensus EPS estimates fall by 64%

Full year 2021 earnings: Revenues in line with analyst expectations

Trulieve Cannabis Corp. Announces Impairment Charges for the Quarter Ended December 31, 2021

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well

Trulieve Cannabis Corp. to Report Q4, 2021 Results on Mar 30, 2022

Investor sentiment deteriorated over the past week

Trulieve Cannabis Corp. (CNSX:TRUL) acquired 64,000 sq. ft. Cultivation Facility in Phoenix.

Trulieve Cannabis Corp. Launches Sweet TalkTM and MomentaTM

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Trulieve First in Florida Market to Offer Live Diamonds, Company's Latest Hydrocarbon Extraction Product

High number of new directors

Trulieve Cannabis Corp. (CNSX:TRUL) acquired PurpleMed Healing Center.

Trulieve Cannabis Corp. Launches TruTonic

Investor sentiment improved over the past week

Trulieve Cannabis Corp. Debuts New Line of Concentrates Using Hydrocarbon Extraction

An unknown buyer acquired Ten Trulieve Cannabis Locations in Floridan from Trulieve Cannabis Corp. (CNSX:TRUL) for $14.8 million.

Trulieve Becomes First MSO to Launch Clone Sales in Massachusetts

Chair, President & CEO recently bought CA$123k worth of stock

Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?

Second quarter 2021 earnings released: EPS US$0.33 (vs US$0.17 in 2Q 2020)

Trulieve Introduces New Brand Portfolio Designed to Serve Consumers in Adult-Use and Medical Markets

High number of new directors

Independent Director Michael O’Donnell has left the company

Independent Director George Hackney has left the company

Trulieve Cannabis Corp. Launches New Innovative Product: Refined Crème

Trulieve Cannabis Corp. (CNSX:TRUL) completed the acquisition of Solevo Wellness West Virginia LLC.

With EPS Growth And More, Trulieve Cannabis (CSE:TRUL) Is Interesting

First quarter 2021 earnings released

Trulieve Cannabis Corp. (CNSX:TRUL) entered into a definitive agreement to acquire Harvest Health & Recreation Inc. (CNSX:HARV) for $1.2 billion.

Trulieve Cannabis Corp. (CNSX:TRUL) completed the acquisition of Mountaineer Holding LLC.

Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?

Full year 2020 earnings released: EPS US$0.56 (vs US$0.48 in FY 2019)

Trulieve Cannabis Corp. Provides Earnings Guidance for the Full Year 2021

Trulieve Cannabis Corp Announces Executive Changes

Trulieve and Morehouse School of Medicine Partner for Cannabis Research and Education

Did Trulieve Cannabis Corp. (CSE:TRUL) Insiders Sell Shares?